Researchers use magnetism to target cells to animal arteries

Scientists have used magnetic fields and tiny iron-bearing particles to drive healthy cells to targeted sites in blood vessels. The research, done in animals, may lead to a new method of delivering cells and genes to repair injured or diseased organs in people.

The study team, led by Robert J. Levy, M.D., the William J. Rashkind Chair of Pediatric Cardiology at The Children’s Hospital of Philadelphia, loaded endothelial cells, flat cells that line the inside of blood vessels, with nanoparticles, tiny spheres nanometers in diameter. The nanoparticles contained iron oxide.

Using an external, uniform magnetic field, Levy’s team directed the cells into steel stents, small metal scaffolds that had been inserted into the carotid arteries of rats. The uniform magnetic field created “magnetic gradients,” local regions of high magnetic force that magnetized both the nanoparticles and the stents, thus increasing the attraction between the particles and their target.

The study appears in the Proceedings of the National Academy of Sciences, published online on Jan. 7. Dr. Levy’s group from Children’s Hospital collaborated with engineers from Drexel University and Duke University.

“This is a novel strategy for delivering cells to targets in the body,” said Levy, who added that previous researchers have pursued other, less successful approaches to introduce endothelial cells to diseased blood vessels, in the developing medical field of cell therapy.

Levy’s team created nanoparticles, approximately 290 nanometers across, made of the biodegradable polymer, polylactic acid, and impregnated with iron oxide.

The researchers loaded the nanoparticles into endothelial cells, which had been genetically modified to produce a specific color that could be detected by an imaging system while the animals were alive. After introducing stainless steel stents into rats’ carotid arteries, Levy’s team used magnetic fields to steer the cells into the stents.

Patients with heart disease commonly receive metal stents in partially blocked blood vessels to improve blood flow, both by widening the vessels and delivering drugs. However, many stents fail over time as smooth muscle cells accumulate excessively on their surfaces and create new blockages. One goal of cell therapy is to introduce new endothelial cells to recoat stents with a smooth surface.

Furthermore, Levy adds, while drug-releasing stents currently provide benefits in treating diseased coronary arteries, they have proved far less effective in treating peripheral vascular disease, such as that occurring in patients with diabetes. In such cases, severe problems in blood circulation may force doctors to amputate a leg. In upcoming animal studies, Levy’s team will use their delivery approach to deliver magnetic nanoparticles to peripheral arteries.

Future studies, Levy added, also will use cells derived from the animal itself, to avoid potential rejection problems that may occur with unmatched cells. The current study used unmatched cells, delivering bovine cells to rat arteries, but only over a 48-hour period, too brief for rejection to occur.

The current study builds on research published earlier this year by Levy and collaborators, in which they used magnetic fields and nanoparticles to deliver DNA to arterial muscle cells in culture. That research focused on a delivery system for gene therapy, while the current study represents cell therapy. Levy suggests future applications may combine both therapies, using endothelial cells to deliver beneficial genes to damaged arteries.

The delivery system, says Levy, might also be applied to other sites where physicians implant steel stents to deliver medication, such as the esophagus, bile ducts and lungs. Another potential use might be in orthopedic procedures, in which surgeons implant steel nails to stabilize fractured bones, or use steel screws to correct spinal abnormalities. In such cases, magnetized nanoparticles might deliver bone stem cells to strengthen bony structures.

“Magnetic fields produced by ordinary MRI machines could suffice to deliver cells to targets where they could promote healing, since MRI uses uniform fields, which are key to our targeting strategy,” added Levy. “This method could become a powerful medical tool.”

Source: Children's Hospital of Philadelphia

Related stories:

Under magnetic force, nanoparticles may deliver gene therapy
After binding DNA segments to tiny iron-containing spheres called nanoparticles, researchers have used magnetic fields to direct the nanoparticles into arterial muscle cells, where the DNA could have a therapeutic effect. Although the research, done in cell cultures, is in early stages, it may represent a new method for delivering gene therapy to benefit blood vessels damaged by arterial disease.
Scientists peel away the mystery behind gold's catalytic prowess
Few materials have exercised as much of a hold on the human imagination, or on human history, as has gold. But for all of its popular uses – money, medals, jewelry and more – gold's potential as a catalyst lay hidden until the 1980s, when Masatake Haruta and Graham Hutchings independently discovered that gold, which had long been considered inactive, could be an extraordinarily good catalyst. Haruta demonstrated the low-temperature oxidation of CO and Hutchings the hydrochlorination of acetylene to vinyl chloride.
Nano-sized 'trojan horse' to aid nutrition
Researchers from Monash University have designed a nano-sized "trojan horse" particle to ensure healing antioxidants can be better absorbed by the human body.
Engineering new uses for gold
The glitter of gold may hold more than just beauty, or so says a team of MIT researchers that is working on ways to use tiny gold rods to fight cancer, deliver drugs and more.
Breaking the 'mucus barrier' with a new drug delivery system
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus — regarded by many as nearly impenetrable — and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
Polymer electric storage, flexible and adaptable
(PhysOrg.com) -- The proliferation of solar, wind and even tidal electric generation and the rapid emergence of hybrid electric automobiles demands flexible and reliable methods of high-capacity electrical storage. Now a team of Penn State materials scientists is developing ferroelectric polymer-based capacitors that can deliver power more rapidly and are much lighter than conventional batteries.
Newly detected air pollutant mimics damaging effects of cigarette smoke
A previously unrecognized group of air pollutants could have effects remarkably similar to harmful substances found in tobacco smoke, Louisiana scientists are reporting in a study scheduled for presentation today at the 236th National Meeting of the American Chemical Society. Inhaling those pollutants exposes the average person up to 300 times more free radicals daily than from smoking one cigarette, they added.
Turning Waste Material into Ethanol
(PhysOrg.com) -- Say the word “biofuels” and most people think of grain ethanol and biodiesel. But there’s another, older technology called gasification that’s getting a new look from researchers at the U.S. Department of Energy’s Ames Laboratory and Iowa State University. By combining gasification with high-tech nanoscale porous catalysts, they hope to create ethanol from a wide range of biomass, including distiller’s grain left over from ethanol production, corn stover from the field, grass, wood pulp, animal waste, and garbage.

News discussion:

Nanotechnology news